{"transactions":[{"id":839788,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2026-03-17T23:47:22.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":6449,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On March 15, 2024, the Reporting Person was granted 19,345 RSUs vesting in three equal annual installments beginning on March 15, 2025. This transaction reflects the second vesting installment of such RSU award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On March 15, 2024, the Reporting Person was granted 19,345 RSUs vesting in three equal annual installments beginning on March 15, 2025. This transaction reflects the second vesting installment of such RSU award."}],"balance_after":6448,"derivative":{"underlying":"Common Stock","underlying_shares":6449},"source":{"system":"sec-edgar","filing":"0001193125-26-111511","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111511/ownership.xml","form_type":"4"}},{"id":839787,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2026-03-17T23:47:22.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":false,"shares":9388,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On March 14, 2025, the Reporting Person was granted 28,165 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On March 14, 2025, the Reporting Person was granted 28,165 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award."}],"balance_after":18777,"derivative":{"underlying":"Common Stock","underlying_shares":9388},"source":{"system":"sec-edgar","filing":"0001193125-26-111511","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111511/ownership.xml","form_type":"4"}},{"id":839786,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2026-03-17T23:47:22.000Z","date":"2026-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":1893,"price":14.2,"value":26880.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Reflects an aggregate of  1,893 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 15, 2026."}],"balance_after":67570,"source":{"system":"sec-edgar","filing":"0001193125-26-111511","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111511/ownership.xml","form_type":"4"}},{"id":839785,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2026-03-17T23:47:22.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":6449,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."}],"balance_after":69463,"source":{"system":"sec-edgar","filing":"0001193125-26-111511","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111511/ownership.xml","form_type":"4"}},{"id":839784,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2026-03-17T23:47:22.000Z","date":"2026-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":4168,"price":14.2,"value":59185.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects an aggregate of 4,694 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs and PSUs that vested on March 14, 2026."}],"balance_after":63014,"source":{"system":"sec-edgar","filing":"0001193125-26-111511","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111511/ownership.xml","form_type":"4"}},{"id":839783,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2026-03-17T23:47:22.000Z","date":"2026-03-14","kind":"grant","planned":false,"acquired":true,"shares":4694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On March 14, 2025, the Reporting Person was granted 14,082 performance-based phantom RSUs (\"PSUs\") with vesting contingent upon the achievement of pre-established performance and strategic targets. This transaction represents the first vesting installment of such PSU award."}],"balance_after":67182,"source":{"system":"sec-edgar","filing":"0001193125-26-111511","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111511/ownership.xml","form_type":"4"}},{"id":839782,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2026-03-17T23:47:22.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":true,"shares":9388,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."}],"balance_after":62488,"source":{"system":"sec-edgar","filing":"0001193125-26-111511","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111511/ownership.xml","form_type":"4"}},{"id":849586,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2026-03-11T20:25:11.000Z","date":"2026-03-09","kind":"exercise","planned":false,"acquired":false,"shares":5465,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 9, 2023, the Reporting Person was granted 16,395 RSUs vesting in three equal annual installments beginning on March 9, 2024. This transaction reflects the third and final vesting installment of such RSU award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 9, 2023, the Reporting Person was granted 16,395 RSUs vesting in three equal annual installments beginning on March 9, 2024. This transaction reflects the third and final vesting installment of such RSU award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5465},"source":{"system":"sec-edgar","filing":"0001193125-26-102240","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526102240/ownership.xml","form_type":"4"}},{"id":849585,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2026-03-11T20:25:11.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":1919,"price":14.96,"value":28708.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects an aggregate of 1,919 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2026."}],"balance_after":53100,"source":{"system":"sec-edgar","filing":"0001193125-26-102240","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526102240/ownership.xml","form_type":"4"}},{"id":849584,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2026-03-11T20:25:11.000Z","date":"2026-03-09","kind":"exercise","planned":false,"acquired":true,"shares":5465,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 800 shares purchased on May 14, 2025 and 800 shares purchased on November 14, 2025."}],"balance_after":55019,"source":{"system":"sec-edgar","filing":"0001193125-26-102240","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526102240/ownership.xml","form_type":"4"}},{"id":1201989,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2025-03-18T21:16:12.000Z","date":"2025-03-17","kind":"exercise","planned":false,"acquired":false,"shares":6448,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 15, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 15, 2025."}],"balance_after":12897,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6448},"source":{"system":"sec-edgar","filing":"0001171843-25-001532","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001532/ownership.xml","form_type":"4"}},{"id":1201988,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2025-03-18T21:16:12.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":13669,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on the vest date. The 13,669 RSUs represent the Target number of shares that may be earned in conjunction with certain market metrics prescribed under the terms of the performance-based phantom RSU award. The award shall cliff vest on the 3rd anniversary of the grant date, subject to the Compensation Committee's determination of achievement of the award prior to the vest date. The number of shares earned and subject to vest, as determined by the Compensation Committee, may be in a range from Threshold (50% of Target) to Maximum (200% of Target). No shares shall vest for achievement under Threshold."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on the vest date. The 13,669 RSUs represent the Target number of shares that may be earned in conjunction with certain market metrics prescribed under the terms of the performance-based phantom RSU award. The award shall cliff vest on the 3rd anniversary of the grant date, subject to the Compensation Committee's determination of achievement of the award prior to the vest date. The number of shares earned and subject to vest, as determined by the Compensation Committee, may be in a range from Threshold (50% of Target) to Maximum (200% of Target). No shares shall vest for achievement under Threshold."}],"balance_after":13669,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13669},"source":{"system":"sec-edgar","filing":"0001171843-25-001532","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001532/ownership.xml","form_type":"4"}},{"id":1201987,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2025-03-18T21:16:12.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":28165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 14, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 14, 2026."}],"balance_after":28165,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":28165},"source":{"system":"sec-edgar","filing":"0001171843-25-001532","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001532/ownership.xml","form_type":"4"}},{"id":1201986,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2025-03-18T21:16:12.000Z","date":"2025-03-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":1893,"price":15.91,"value":30117.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects an aggregate of 1,893 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the closing price of ANIK common stock on March 14, 2025, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":47954,"source":{"system":"sec-edgar","filing":"0001171843-25-001532","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001532/ownership.xml","form_type":"4"}},{"id":1201985,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2025-03-18T21:16:12.000Z","date":"2025-03-17","kind":"exercise","planned":false,"acquired":true,"shares":6448,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the first vesting installment of RSUs granted on March 15, 2024, which the Company elected to settle in shares."}],"balance_after":49847,"source":{"system":"sec-edgar","filing":"0001171843-25-001532","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001532/ownership.xml","form_type":"4"}},{"id":1208411,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2025-03-13T21:18:40.000Z","date":"2025-03-11","kind":"exercise","planned":false,"acquired":false,"shares":7663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":7663},"source":{"system":"sec-edgar","filing":"0001171843-25-001468","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001468/ownership.xml","form_type":"4"}},{"id":1208410,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2025-03-13T21:18:40.000Z","date":"2025-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":2250,"price":16.79,"value":37777.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects an aggregate of 2,250 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the closing price of ANIK common stock on March 11, 2025, the trading day to which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":43399,"source":{"system":"sec-edgar","filing":"0001171843-25-001468","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001468/ownership.xml","form_type":"4"}},{"id":1208409,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2025-03-13T21:18:40.000Z","date":"2025-03-11","kind":"exercise","planned":false,"acquired":true,"shares":7663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the third and final vesting installment of RSUs granted on March 11, 2022."}],"balance_after":45649,"source":{"system":"sec-edgar","filing":"0001171843-25-001468","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001468/ownership.xml","form_type":"4"}},{"id":1213500,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2025-03-11T21:17:58.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":false,"shares":5465,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024."}],"balance_after":5465,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5465},"source":{"system":"sec-edgar","filing":"0001171843-25-001405","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001405/ownership.xml","form_type":"4"}},{"id":1213499,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2025-03-11T21:17:58.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1604,"price":16.62,"value":26658.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects an aggregate of 1,604 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the closing price of ANIK common stock on March 7, 2025, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":37986,"source":{"system":"sec-edgar","filing":"0001171843-25-001405","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001405/ownership.xml","form_type":"4"}},{"id":1213498,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2025-03-11T21:17:58.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":5465,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the second vesting installment of RSUs granted on March 9, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 800 shares purchased on May 14, 2024 and 330 shares purchased on November 14, 2024."}],"balance_after":39590,"source":{"system":"sec-edgar","filing":"0001171843-25-001405","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001405/ownership.xml","form_type":"4"}},{"id":1570708,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-19T21:17:45.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":46875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents a 10% premium above the closing price of Anika's common stock on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The premium priced stock options vest in three equal annual installments beginning on March 15, 2025."}],"balance_after":46875,"derivative":{"exercise_price":27.98,"expiration_date":"2034-03-11","underlying":"Common Stock","underlying_shares":46875},"source":{"system":"sec-edgar","filing":"0001171843-24-001460","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001460/ownership.xml","form_type":"4"}},{"id":1570707,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2024-03-19T21:17:45.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":19345,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 15, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 15, 2025."}],"balance_after":19345,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":19345},"source":{"system":"sec-edgar","filing":"0001171843-24-001460","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001460/ownership.xml","form_type":"4"}},{"id":1582391,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2024-03-13T00:03:49.000Z","date":"2024-03-11","kind":"exercise","planned":false,"acquired":false,"shares":7662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023."}],"balance_after":7663,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":7662},"source":{"system":"sec-edgar","filing":"0001171843-24-001306","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001306/ownership.xml","form_type":"4"}},{"id":1582390,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2024-03-13T00:03:49.000Z","date":"2024-03-11","kind":"exercise","planned":false,"acquired":false,"shares":5465,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024."}],"balance_after":10930,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5465},"source":{"system":"sec-edgar","filing":"0001171843-24-001306","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001306/ownership.xml","form_type":"4"}},{"id":1582389,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2024-03-13T00:03:49.000Z","date":"2024-03-11","kind":"exercise","planned":false,"acquired":false,"shares":3682,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3682},"source":{"system":"sec-edgar","filing":"0001171843-24-001306","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001306/ownership.xml","form_type":"4"}},{"id":1582388,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2024-03-13T00:03:49.000Z","date":"2024-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":2250,"price":25.79,"value":58027.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F8","text":"Reflects an aggregate of 2,250 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Reflects the closing price of ANIK common stock on March 11, 2024, the trading day on which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":32995,"source":{"system":"sec-edgar","filing":"0001171843-24-001306","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001306/ownership.xml","form_type":"4"}},{"id":1582387,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2024-03-13T00:03:49.000Z","date":"2024-03-11","kind":"exercise","planned":false,"acquired":true,"shares":7662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"Reflects the second vesting installment of RSUs granted on March 11, 2022."}],"balance_after":35245,"source":{"system":"sec-edgar","filing":"0001171843-24-001306","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001306/ownership.xml","form_type":"4"}},{"id":1582386,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2024-03-13T00:03:49.000Z","date":"2024-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":1605,"price":25.42,"value":40799.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Reflects an aggregate of 1,605 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the closing price of ANIK common stock on March 8, 2024, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":27583,"source":{"system":"sec-edgar","filing":"0001171843-24-001306","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001306/ownership.xml","form_type":"4"}},{"id":1582385,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2024-03-13T00:03:49.000Z","date":"2024-03-11","kind":"exercise","planned":false,"acquired":true,"shares":5465,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Reflects the first vesting installment of RSUs granted on March 9, 2023."}],"balance_after":29188,"source":{"system":"sec-edgar","filing":"0001171843-24-001306","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001306/ownership.xml","form_type":"4"}},{"id":1582384,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2024-03-13T00:03:49.000Z","date":"2024-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":1081,"price":25.42,"value":27479.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects an aggregate of 1,081 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the closing price of ANIK common stock on March 8, 2024, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":23723,"source":{"system":"sec-edgar","filing":"0001171843-24-001306","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001306/ownership.xml","form_type":"4"}},{"id":1582383,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2024-03-13T00:03:49.000Z","date":"2024-03-11","kind":"exercise","planned":false,"acquired":true,"shares":3682,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 642 shares on May 12, 2023 and 192 shares on November 14, 2023."}],"balance_after":24804,"source":{"system":"sec-edgar","filing":"0001171843-24-001306","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001306/ownership.xml","form_type":"4"}},{"id":1955347,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2023-03-14T20:46:54.000Z","date":"2023-03-10","kind":"exercise","acquired":false,"shares":7663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023."}],"balance_after":15325,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":7663},"source":{"system":"sec-edgar","filing":"0001171843-23-001685","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184323001685/ownership.xml","form_type":"4"}},{"id":1955346,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2023-03-14T20:46:54.000Z","date":"2023-03-10","kind":"tax_withholding","acquired":false,"shares":2250,"price":26.1,"value":58725.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects an aggregate of 2,250 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the closing price of ANIK common stock on March 10, 2023, the trading day immediately preceding the date on which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":20288,"source":{"system":"sec-edgar","filing":"0001171843-23-001685","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184323001685/ownership.xml","form_type":"4"}},{"id":1955345,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2023-03-14T20:46:54.000Z","date":"2023-03-10","kind":"exercise","acquired":true,"shares":7663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the first vesting installment of Restricted Stock Units (RSUs) granted on March 11, 2022."}],"balance_after":22538,"source":{"system":"sec-edgar","filing":"0001171843-23-001685","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184323001685/ownership.xml","form_type":"4"}},{"id":1959620,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2023-03-10T21:51:39.000Z","date":"2023-03-09","kind":"exercise","acquired":false,"shares":3683,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022."}],"balance_after":3682,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3683},"source":{"system":"sec-edgar","filing":"0001171843-23-001596","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184323001596/ownership.xml","form_type":"4"}},{"id":1959619,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-10T21:51:39.000Z","date":"2023-03-09","kind":"grant","acquired":true,"shares":35790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Represents a 10% premium above the closing price of Anika's common stock on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The premium priced stock options vest in three equal annual installments beginning on March 9, 2024."}],"balance_after":35790,"derivative":{"exercise_price":29.6,"expiration_date":"2033-03-09","underlying":"Common Stock","underlying_shares":35790},"source":{"system":"sec-edgar","filing":"0001171843-23-001596","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184323001596/ownership.xml","form_type":"4"}},{"id":1959618,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2023-03-10T21:51:39.000Z","date":"2023-03-09","kind":"grant","acquired":true,"shares":16395,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024."}],"balance_after":16395,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":16395},"source":{"system":"sec-edgar","filing":"0001171843-23-001596","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184323001596/ownership.xml","form_type":"4"}},{"id":1959617,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2023-03-10T21:51:39.000Z","date":"2023-03-09","kind":"tax_withholding","acquired":false,"shares":1081,"price":26.91,"value":29089.71,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects an aggregate of 1,081 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the closing price of ANIK common stock on March 9, 2023, the trading day on which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":14875,"source":{"system":"sec-edgar","filing":"0001171843-23-001596","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184323001596/ownership.xml","form_type":"4"}},{"id":1959616,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2023-03-10T21:51:39.000Z","date":"2023-03-09","kind":"exercise","acquired":true,"shares":3683,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the second vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021."}],"balance_after":15956,"source":{"system":"sec-edgar","filing":"0001171843-23-001596","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184323001596/ownership.xml","form_type":"4"}},{"id":1967096,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2023-03-07T21:34:40.000Z","date":"2023-03-04","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vested in three equal annual installments beginning March 4, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vested in three equal annual installments beginning March 4, 2021."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001171843-23-001480","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184323001480/ownership.xml","form_type":"4"}},{"id":1967095,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2023-03-07T21:34:40.000Z","date":"2023-03-04","kind":"tax_withholding","acquired":false,"shares":734,"price":31.59,"value":23187.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects an aggregate of 734 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 4, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the closing price of ANIK common stock on March 3, 2023, the trading day on which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":12273,"source":{"system":"sec-edgar","filing":"0001171843-23-001480","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184323001480/ownership.xml","form_type":"4"}},{"id":1967094,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2023-03-07T21:34:40.000Z","date":"2023-03-04","kind":"exercise","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on March 4, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 640 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on May 13, 2022."}],"balance_after":13007,"source":{"system":"sec-edgar","filing":"0001171843-23-001480","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184323001480/ownership.xml","form_type":"4"}},{"id":2274045,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2022-05-12T12:30:59.000Z","date":"2022-05-11","kind":"purchase","acquired":true,"shares":1500,"price":21.37,"value":32055.0,"ownership":{"direct":true},"balance_after":9867,"source":{"system":"sec-edgar","filing":"0001171843-22-003615","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184322003615/ownership.xml","form_type":"4"}},{"id":2331711,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2022-03-16T13:01:06.000Z","date":"2022-03-14","kind":"purchase","acquired":true,"shares":1500,"price":26.652,"value":39978.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 14, 2022, Mr. Colleran purchased 1,500 shares in multiple trades ranging from $26.58 to $26.71. The price reported above reflects the weighted average purchase price. Mr. Colleran undertakes to provide the Securities and Exchange Commission staff, the issuer, or any security holder, upon request, full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":8367,"source":{"system":"sec-edgar","filing":"0001171843-22-001915","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184322001915/ownership.xml","form_type":"4"}},{"id":2334270,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-15T21:01:47.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":35864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents a 10% premium above the closing price of Anika's common stock on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The premium priced stock options vest in three equal annual installments beginning on March 11, 2023."}],"balance_after":35864,"derivative":{"exercise_price":28.14,"expiration_date":"2032-03-11","underlying":"Common Stock","underlying_shares":35864},"source":{"system":"sec-edgar","filing":"0001171843-22-001906","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184322001906/ownership.xml","form_type":"4"}},{"id":2334269,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2022-03-15T21:01:47.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":22988,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023."}],"balance_after":22988,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":22988},"source":{"system":"sec-edgar","filing":"0001171843-22-001906","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184322001906/ownership.xml","form_type":"4"}},{"id":2338434,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2022-03-11T22:36:01.000Z","date":"2022-03-09","kind":"exercise","acquired":false,"shares":3682,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022."}],"balance_after":7365,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3682},"source":{"system":"sec-edgar","filing":"0001171843-22-001810","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184322001810/ownership.xml","form_type":"4"}},{"id":2338433,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2022-03-11T22:36:01.000Z","date":"2022-03-09","kind":"tax_withholding","acquired":false,"shares":1081,"price":26.22,"value":28343.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects an aggregate of 1,081 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the closing price of ANIK common stock on March 9, 2022, the trading day on which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":6867,"source":{"system":"sec-edgar","filing":"0001171843-22-001810","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184322001810/ownership.xml","form_type":"4"}},{"id":2338432,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2022-03-11T22:36:01.000Z","date":"2022-03-09","kind":"exercise","acquired":true,"shares":3682,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the first vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021."}],"balance_after":7948,"source":{"system":"sec-edgar","filing":"0001171843-22-001810","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184322001810/ownership.xml","form_type":"4"}},{"id":2348779,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2022-03-07T13:00:54.000Z","date":"2022-03-04","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 4, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 4, 2021."}],"balance_after":2500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001171843-22-001664","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184322001664/ownership.xml","form_type":"4"}},{"id":2348778,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2022-03-07T13:00:54.000Z","date":"2022-03-04","kind":"tax_withholding","acquired":false,"shares":734,"price":31.06,"value":22798.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects an aggregate of 734 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 4, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the closing price of ANIK common stock on March 4, 2022, the trading day on which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":4266,"source":{"system":"sec-edgar","filing":"0001171843-22-001664","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184322001664/ownership.xml","form_type":"4"}},{"id":2348777,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2022-03-07T13:00:54.000Z","date":"2022-03-04","kind":"exercise","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the second vesting installment of Restricted Stock Units (RSUs) granted on March 4, 2020."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001171843-22-001664","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184322001664/ownership.xml","form_type":"4"}},{"id":2795529,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-11T22:09:06.000Z","date":"2021-03-09","kind":"grant","acquired":true,"shares":27681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents a 10% premium above the closing price of Anika's common stock on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The premium priced stock options vest in three equal annual installments beginning on March 9, 2022."}],"balance_after":27681,"derivative":{"exercise_price":37.4,"expiration_date":"2031-03-09","underlying":"Common Stock","underlying_shares":27681},"source":{"system":"sec-edgar","filing":"0001171843-21-001709","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184321001709/ownership.xml","form_type":"4"}},{"id":2795528,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2021-03-11T22:09:06.000Z","date":"2021-03-09","kind":"grant","acquired":true,"shares":11047,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022."}],"balance_after":11047,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11047},"source":{"system":"sec-edgar","filing":"0001171843-21-001709","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184321001709/ownership.xml","form_type":"4"}},{"id":2804165,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2021-03-08T22:06:49.000Z","date":"2021-03-04","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 4, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 4, 2021."}],"balance_after":5000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001171843-21-001598","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184321001598/ownership.xml","form_type":"4"}},{"id":2804164,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2021-03-08T22:06:49.000Z","date":"2021-03-04","kind":"exercise","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the first vesting installment of RSUs granted on March 4, 2020."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001171843-21-001598","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184321001598/ownership.xml","form_type":"4"}},{"id":3223358,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-06T21:10:29.000Z","date":"2020-03-04","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest in three equal annual installments beginning March 4, 2021."}],"balance_after":35000,"derivative":{"exercise_price":43.06,"expiration_date":"2030-03-04","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001171843-20-001547","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184320001547/ownership.xml","form_type":"4"}},{"id":3223357,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2020-03-06T21:10:29.000Z","date":"2020-03-04","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 4, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 4, 2021."}],"balance_after":7500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001171843-20-001547","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184320001547/ownership.xml","form_type":"4"}},{"id":3562984,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-04T20:02:31.000Z","date":"2019-04-02","kind":"exercise","acquired":false,"shares":7395,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment."}],"balance_after":3698,"derivative":{"exercise_price":30.98,"expiration_date":"2025-06-29","underlying":"Common Stock","underlying_shares":7395},"source":{"system":"sec-edgar","filing":"0001127602-19-014797","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219014797/form4.xml","form_type":"4"}},{"id":3562983,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Common Stock","published_at":"2019-04-04T20:02:31.000Z","date":"2019-04-02","kind":"sale","acquired":false,"shares":7395,"price":94.89,"value":701711.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,443 restricted stock units granted on February 22, 2017, which vest on February 22, 2020; and 1,790 restricted stock units granted on February 14, 2018, which vest as to one-half of the total units on February 14, 2020 and one-half of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":30433,"source":{"system":"sec-edgar","filing":"0001127602-19-014797","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219014797/form4.xml","form_type":"4"}},{"id":3562982,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Common Stock","published_at":"2019-04-04T20:02:31.000Z","date":"2019-04-02","kind":"exercise","acquired":true,"shares":7395,"price":30.98,"value":229097.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,443 restricted stock units granted on February 22, 2017, which vest on February 22, 2020; and 1,790 restricted stock units granted on February 14, 2018, which vest as to one-half of the total units on February 14, 2020 and one-half of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":37828,"source":{"system":"sec-edgar","filing":"0001127602-19-014797","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219014797/form4.xml","form_type":"4"}},{"id":3613946,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-03-06T00:15:40.000Z","date":"2019-03-01","kind":"exercise","acquired":false,"shares":1748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment."}],"balance_after":5247,"derivative":{"exercise_price":74.5,"expiration_date":"2028-02-14","underlying":"Common Stock","underlying_shares":1748},"source":{"system":"sec-edgar","filing":"0001127602-19-010077","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219010077/form4.xml","form_type":"4"}},{"id":3613945,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-03-06T00:15:40.000Z","date":"2019-03-01","kind":"exercise","acquired":false,"shares":1422,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment."}],"balance_after":5686,"derivative":{"exercise_price":46.22,"expiration_date":"2027-02-22","underlying":"Common Stock","underlying_shares":1422},"source":{"system":"sec-edgar","filing":"0001127602-19-010077","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219010077/form4.xml","form_type":"4"}},{"id":3613944,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-03-06T00:15:40.000Z","date":"2019-03-01","kind":"exercise","acquired":false,"shares":1166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment."}],"balance_after":5831,"derivative":{"exercise_price":29.26,"expiration_date":"2026-02-24","underlying":"Common Stock","underlying_shares":1166},"source":{"system":"sec-edgar","filing":"0001127602-19-010077","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219010077/form4.xml","form_type":"4"}},{"id":3613943,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-03-06T00:15:40.000Z","date":"2019-03-01","kind":"exercise","acquired":false,"shares":16639,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment."}],"balance_after":11093,"derivative":{"exercise_price":30.98,"expiration_date":"2025-06-29","underlying":"Common Stock","underlying_shares":16639},"source":{"system":"sec-edgar","filing":"0001127602-19-010077","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219010077/form4.xml","form_type":"4"}},{"id":3613942,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Common Stock","published_at":"2019-03-06T00:15:40.000Z","date":"2019-03-01","kind":"sale","acquired":false,"shares":20975,"price":94.6536,"value":1985359.26,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the weighted average sale price of the shares sold.  The shares were sold at varying prices in the range of $94.37 to $94.99.  The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,443 restricted stock units granted on February 22, 2017, which vest on February 22, 2020; and 1,790 restricted stock units granted on February 14, 2018, which vest as to one-half of the total units on February 14, 2020 and one-half of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":30433,"source":{"system":"sec-edgar","filing":"0001127602-19-010077","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219010077/form4.xml","form_type":"4"}},{"id":3613941,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Common Stock","published_at":"2019-03-06T00:15:40.000Z","date":"2019-03-01","kind":"exercise","acquired":true,"shares":1748,"price":74.5,"value":130226.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,443 restricted stock units granted on February 22, 2017, which vest on February 22, 2020; and 1,790 restricted stock units granted on February 14, 2018, which vest as to one-half of the total units on February 14, 2020 and one-half of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":51408,"source":{"system":"sec-edgar","filing":"0001127602-19-010077","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219010077/form4.xml","form_type":"4"}},{"id":3613940,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Common Stock","published_at":"2019-03-06T00:15:40.000Z","date":"2019-03-01","kind":"exercise","acquired":true,"shares":1422,"price":46.22,"value":65724.84,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,443 restricted stock units granted on February 22, 2017, which vest on February 22, 2020; and 1,790 restricted stock units granted on February 14, 2018, which vest as to one-half of the total units on February 14, 2020 and one-half of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":49660,"source":{"system":"sec-edgar","filing":"0001127602-19-010077","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219010077/form4.xml","form_type":"4"}},{"id":3613939,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Common Stock","published_at":"2019-03-06T00:15:40.000Z","date":"2019-03-01","kind":"exercise","acquired":true,"shares":1166,"price":29.26,"value":34117.16,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,443 restricted stock units granted on February 22, 2017, which vest on February 22, 2020; and 1,790 restricted stock units granted on February 14, 2018, which vest as to one-half of the total units on February 14, 2020 and one-half of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":48238,"source":{"system":"sec-edgar","filing":"0001127602-19-010077","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219010077/form4.xml","form_type":"4"}},{"id":3613938,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Common Stock","published_at":"2019-03-06T00:15:40.000Z","date":"2019-03-01","kind":"exercise","acquired":true,"shares":16639,"price":30.98,"value":515476.22,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,443 restricted stock units granted on February 22, 2017, which vest on February 22, 2020; and 1,790 restricted stock units granted on February 14, 2018, which vest as to one-half of the total units on February 14, 2020 and one-half of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":47072,"source":{"system":"sec-edgar","filing":"0001127602-19-010077","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219010077/form4.xml","form_type":"4"}},{"id":3632596,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Common Stock","published_at":"2019-02-27T00:06:30.000Z","date":"2019-02-24","kind":"tax_withholding","acquired":false,"shares":3107,"price":87.6,"value":272173.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,443 restricted stock units granted on February 22, 2017, which vest on February 22, 2020; and 1,790 restricted stock units granted on February 14, 2018, which vest as to one-half of the total units on February 14, 2020 and one-half of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":30433,"source":{"system":"sec-edgar","filing":"0001127602-19-008491","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219008491/form4.xml","form_type":"4"}},{"id":3632595,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Common Stock","published_at":"2019-02-27T00:06:30.000Z","date":"2019-02-22","kind":"tax_withholding","acquired":false,"shares":641,"price":87.6,"value":56151.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,279 restricted stock units granted on February 24, 2016, which vest on February 24, 2019; 5,982 performance share units granted on February 24, 2016, which vest on February 24, 2019; 1,443 restricted stock units granted on February 22, 2017, which vest on February 22, 2020; and 1,790 restricted stock units granted on February 14, 2018, which vest as to one-half of the total units on February 14, 2020 and one-half of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":33540,"source":{"system":"sec-edgar","filing":"0001127602-19-008491","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219008491/form4.xml","form_type":"4"}},{"id":3650297,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Common Stock","published_at":"2019-02-19T22:18:44.000Z","date":"2019-02-14","kind":"tax_withholding","acquired":false,"shares":264,"price":84.83,"value":22395.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,279 restricted stock units granted on February 24, 2016, which vest on February 24, 2019; 5,982 performance share units granted on February 24, 2016, which vest on February 24, 2019; 2,885 restricted stock units granted on February 22, 2017, which vest one-half of the total units on February 22, 2019 and one-half of the total units on February 22, 2020; and 1,790 restricted stock units granted on February 14, 2018, which vest as to one-half of the total units on February 14, 2020 and one-half of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":34181,"source":{"system":"sec-edgar","filing":"0001127602-19-006919","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219006919/form4.xml","form_type":"4"}},{"id":3672427,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-02-06T21:34:41.000Z","date":"2019-02-05","kind":"exercise","acquired":false,"shares":6834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment."}],"balance_after":6997,"derivative":{"exercise_price":29.26,"expiration_date":"2026-02-24","underlying":"Common Stock","underlying_shares":6834},"source":{"system":"sec-edgar","filing":"0001127602-19-004324","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219004324/form4.xml","form_type":"4"}},{"id":3672426,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Common Stock","published_at":"2019-02-06T21:34:41.000Z","date":"2019-02-05","kind":"sale","acquired":false,"shares":6834,"price":80.72,"value":551640.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,279 restricted stock units granted on February 24, 2016, which vest on February 24, 2019; 5,982 performance share units granted on February 24, 2016, which vest on February 24, 2019; 2,885 restricted stock units granted on February 22, 2017, which vest one-half of the total units on February 22, 2019 and one-half of the total units on February 22, 2020; and 2,685 restricted stock units granted on February 14, 2018, which vest as to one-third of the total units on February 14, 2019, one-third of the total units on February 14, 2020 and one-third of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":34133,"source":{"system":"sec-edgar","filing":"0001127602-19-004324","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219004324/form4.xml","form_type":"4"}},{"id":3672425,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Common Stock","published_at":"2019-02-06T21:34:41.000Z","date":"2019-02-05","kind":"exercise","acquired":true,"shares":6834,"price":29.26,"value":199962.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,279 restricted stock units granted on February 24, 2016, which vest on February 24, 2019; 5,982 performance share units granted on February 24, 2016, which vest on February 24, 2019; 2,885 restricted stock units granted on February 22, 2017, which vest one-half of the total units on February 22, 2019 and one-half of the total units on February 22, 2020; and 2,685 restricted stock units granted on February 14, 2018, which vest as to one-third of the total units on February 14, 2019, one-third of the total units on February 14, 2020 and one-third of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":40967,"source":{"system":"sec-edgar","filing":"0001127602-19-004324","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219004324/form4.xml","form_type":"4"}},{"id":3679816,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-02-01T22:29:19.000Z","date":"2019-01-31","kind":"exercise","acquired":false,"shares":4826,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment."}],"balance_after":13831,"derivative":{"exercise_price":29.26,"expiration_date":"2026-02-24","underlying":"Common Stock","underlying_shares":4826},"source":{"system":"sec-edgar","filing":"0001127602-19-003443","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219003443/form4.xml","form_type":"4"}},{"id":3679815,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Common Stock","published_at":"2019-02-01T22:29:19.000Z","date":"2019-01-31","kind":"sale","acquired":false,"shares":4826,"price":80,"value":386080.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,279 restricted stock units granted on February 24, 2016, which vest on February 24, 2019; 5,982 performance share units granted on February 24, 2016, which vest on February 24, 2019; 2,885 restricted stock units granted on February 22, 2017, which vest one-half of the total units on February 22, 2019 and one-half of the total units on February 22, 2020; and 2,685 restricted stock units granted on February 14, 2018, which vest as to one-third of the total units on February 14, 2019, one-third of the total units on February 14, 2020 and one-third of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 91 shares acquired under the Insulet Corporation 2007 Employee Stock Purchase Plan on November 30, 2018."}],"balance_after":34133,"source":{"system":"sec-edgar","filing":"0001127602-19-003443","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219003443/form4.xml","form_type":"4"}},{"id":3679814,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Common Stock","published_at":"2019-02-01T22:29:19.000Z","date":"2019-01-31","kind":"exercise","acquired":true,"shares":4826,"price":29.26,"value":141208.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,279 restricted stock units granted on February 24, 2016, which vest on February 24, 2019; 5,982 performance share units granted on February 24, 2016, which vest on February 24, 2019; 2,885 restricted stock units granted on February 22, 2017, which vest one-half of the total units on February 22, 2019 and one-half of the total units on February 22, 2020; and 2,685 restricted stock units granted on February 14, 2018, which vest as to one-third of the total units on February 14, 2019, one-third of the total units on February 14, 2020 and one-third of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 91 shares acquired under the Insulet Corporation 2007 Employee Stock Purchase Plan on November 30, 2018."}],"balance_after":38959,"source":{"system":"sec-edgar","filing":"0001127602-19-003443","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219003443/form4.xml","form_type":"4"}},{"id":3763384,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-11-15T21:24:27.000Z","date":"2018-11-14","kind":"exercise","acquired":false,"shares":4264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment."}],"balance_after":7108,"derivative":{"exercise_price":46.22,"expiration_date":"2027-02-22","underlying":"Common Stock","underlying_shares":4264},"source":{"system":"sec-edgar","filing":"0001127602-18-033174","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760218033174/form4.xml","form_type":"4"}},{"id":3763383,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-11-15T21:24:27.000Z","date":"2018-11-14","kind":"exercise","acquired":false,"shares":1849,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment."}],"balance_after":27732,"derivative":{"exercise_price":30.98,"expiration_date":"2025-06-29","underlying":"Common Stock","underlying_shares":1849},"source":{"system":"sec-edgar","filing":"0001127602-18-033174","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760218033174/form4.xml","form_type":"4"}},{"id":3763382,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Common Stock","published_at":"2018-11-15T21:24:27.000Z","date":"2018-11-14","kind":"sale","acquired":false,"shares":6113,"price":80.41,"value":491546.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,279 restricted stock units granted on February 24, 2016, which vest on February 24, 2019; 5,982 performance share units granted on February 24, 2016, which vest on February 24, 2019; 2,885 restricted stock units granted on February 22, 2017, which vest one-half of the total units on February 22, 2019 and one-half of the total units on February 22, 2020; and 2,685 restricted stock units granted on February 14, 2018, which vest as to one-third of the total units on February 14, 2019, one-third of the total units on February 14, 2020 and one-third of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":34042,"source":{"system":"sec-edgar","filing":"0001127602-18-033174","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760218033174/form4.xml","form_type":"4"}},{"id":3763381,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Common Stock","published_at":"2018-11-15T21:24:27.000Z","date":"2018-11-14","kind":"exercise","acquired":true,"shares":4264,"price":46.22,"value":197082.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,279 restricted stock units granted on February 24, 2016, which vest on February 24, 2019; 5,982 performance share units granted on February 24, 2016, which vest on February 24, 2019; 2,885 restricted stock units granted on February 22, 2017, which vest one-half of the total units on February 22, 2019 and one-half of the total units on February 22, 2020; and 2,685 restricted stock units granted on February 14, 2018, which vest as to one-third of the total units on February 14, 2019, one-third of the total units on February 14, 2020 and one-third of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":40155,"source":{"system":"sec-edgar","filing":"0001127602-18-033174","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760218033174/form4.xml","form_type":"4"}},{"id":3763380,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Common Stock","published_at":"2018-11-15T21:24:27.000Z","date":"2018-11-14","kind":"exercise","acquired":true,"shares":1849,"price":30.98,"value":57282.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,279 restricted stock units granted on February 24, 2016, which vest on February 24, 2019; 5,982 performance share units granted on February 24, 2016, which vest on February 24, 2019; 2,885 restricted stock units granted on February 22, 2017, which vest one-half of the total units on February 22, 2019 and one-half of the total units on February 22, 2020; and 2,685 restricted stock units granted on February 14, 2018, which vest as to one-third of the total units on February 14, 2019, one-third of the total units on February 14, 2020 and one-third of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":35891,"source":{"system":"sec-edgar","filing":"0001127602-18-033174","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760218033174/form4.xml","form_type":"4"}},{"id":3875827,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Common Stock","published_at":"2018-07-03T20:03:21.000Z","date":"2018-06-29","kind":"tax_withholding","acquired":false,"shares":3205,"price":85.7,"value":274668.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,279 restricted stock units granted on February 24, 2016, which vest on February 24, 2019; 5,982 performance share units granted on February 24, 2016, which vest on February 24, 2019; 2,885 restricted stock units granted on February 22, 2017, which vest one-half of the total units on February 22, 2019 and one-half of the total units on February 22, 2020; and 2,685 restricted stock units granted on February 14, 2018, which vest as to one-third of the total units on February 14, 2019, one-third of the total units on February 14, 2020 and one-third of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 108 shares acquired under the Insulet Corporation 2007 Employee Stock Purchase Plan on May 31, 2018."}],"balance_after":34042,"source":{"system":"sec-edgar","filing":"0001127602-18-022579","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760218022579/form4.xml","form_type":"4"}},{"id":3931118,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Common Stock","published_at":"2018-05-16T20:33:02.000Z","date":"2018-05-15","kind":"sale","acquired":false,"shares":4956,"price":86.24,"value":427405.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,209 restricted stock units granted on June 29, 2015, which vest on June 29, 2018; 2,279 restricted stock units granted on February 24, 2016, which vest on February 24, 2019; 5,982 performance share units granted on February 24, 2016, which vest on February 24, 2019; 2,885 restricted stock units granted on February 22, 2017, which vest one-half of the total units on February 22, 2019 and one-half of the total units on February 22, 2020; and 2,685 restricted stock units granted on February 14, 2018, which vest as to one-third of the total units on February 14, 2019, one-third of the total units on February 14, 2020 and one-third of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":37139,"source":{"system":"sec-edgar","filing":"0001127602-18-017690","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760218017690/form4.xml","form_type":"4"}},{"id":4030726,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Common Stock","published_at":"2018-02-27T23:23:11.000Z","date":"2018-02-24","kind":"tax_withholding","acquired":false,"shares":671,"price":75.55,"value":50694.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,209 restricted stock units granted on June 29, 2015, which vest on June 29, 2018; 2,279 restricted stock units granted on February 24, 2016, which vest on February 24, 2019; 5,982 performance share units granted on February 24, 2016, which vest on February 24, 2019; 2,885 restricted stock units granted on February 22, 2017, which vest one-half of the total units on February 22, 2019 and one-half of the total units on February 22, 2020; and 2,685 restricted stock units granted on February 14, 2018, which vest as to one-third of the total units on February 14, 2019, one-third of the total units on February 14, 2020 and one-third of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes an aggregate of 406 shares acquired under the Insulet Corporation 2007 Employee Stock Purchase Plan on the following dates: 94 shares acquired on November 30, 2016, 117 shares acquired on May 31, 2017 and 195 shares acquired on November 30, 2017."}],"balance_after":42095,"source":{"system":"sec-edgar","filing":"0001127602-18-008812","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760218008812/form4.xml","form_type":"4"}},{"id":4030725,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Common Stock","published_at":"2018-02-27T23:23:11.000Z","date":"2018-02-24","kind":"tax_withholding","acquired":false,"shares":1759,"price":75.55,"value":132892.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,209 restricted stock units granted on June 29, 2015, which vest on June 29, 2018; 2,279 restricted stock units granted on February 24, 2016, which vest on February 24, 2019; 5,982 performance share units granted on February 24, 2016, which vest on February 24, 2019; 2,885 restricted stock units granted on February 22, 2017, which vest one-half of the total units on February 22, 2019 and one-half of the total units on February 22, 2020; and 2,685 restricted stock units granted on February 14, 2018, which vest as to one-third of the total units on February 14, 2019, one-third of the total units on February 14, 2020 and one-third of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes an aggregate of 406 shares acquired under the Insulet Corporation 2007 Employee Stock Purchase Plan on the following dates: 94 shares acquired on November 30, 2016, 117 shares acquired on May 31, 2017 and 195 shares acquired on November 30, 2017."}],"balance_after":42766,"source":{"system":"sec-edgar","filing":"0001127602-18-008812","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760218008812/form4.xml","form_type":"4"}},{"id":4034344,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Common Stock","published_at":"2018-02-27T01:04:23.000Z","date":"2018-02-22","kind":"tax_withholding","acquired":false,"shares":470,"price":80.46,"value":37816.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,209 restricted stock units granted on June 29, 2015, which vest on June 29, 2018; 4,557 restricted stock units granted on February 24, 2016, which vest one-half of the total units on February 24, 2018 and one-half of the total units on February 24, 2019; 11,962 performance share units granted on February 24, 2016, which vest as to one-half of the total units on February 24, 2018 and one-half of the total units on February 24, 2019; 2,885 restricted stock units granted on February 22, 2017, which vest one-half of the total units on February 22, 2019, and one-half of the total units on February 22, 2020; and 2,685 restricted stock units granted on February 14, 2018, which vest as to one-third of the total units on February 14, 2019, one-third of the total units on February 14, 2020 and one-third of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes an aggregate of 406 shares acquired under the Insulet Corporation 2007 Employee Stock Purchase Plan on the following dates: 94 shares acquired on November 30, 2016, 117 shares acquired on May 31, 2017 and 195 shares acquired on November 30, 2017."}],"balance_after":44525,"source":{"system":"sec-edgar","filing":"0001127602-18-008527","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760218008527/form4.xml","form_type":"4"}},{"id":4055301,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-02-16T01:07:39.000Z","date":"2018-02-14","kind":"grant","acquired":true,"shares":6995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment."}],"balance_after":6995,"derivative":{"exercise_price":74.5,"expiration_date":"2028-02-14","underlying":"Common Stock","underlying_shares":6995},"source":{"system":"sec-edgar","filing":"0001127602-18-006481","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760218006481/form4.xml","form_type":"4"}},{"id":4055300,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Common Stock","published_at":"2018-02-16T01:07:39.000Z","date":"2018-02-14","kind":"grant","acquired":true,"shares":2685,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The 2,685 restricted stock units vest one-third of the total units on February 14, 2019, one-third of the total units on February 14, 2020 and one-third of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,209 restricted stock units granted on June 29, 2015, which vest on June 29, 2018; 4,557 restricted stock units granted on February 24, 2016, which vest one-half of the total units on February 24, 2018 and one-half of the total units on February 24, 2019; and 4,327 restricted stock units granted on February 22, 2017, which vest one-third of the total units on February 22, 2018, and one-third of the total units on February 22, 2019, and one-third of the total units on February 22, 2020, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes an aggregate of 406 shares acquired under the Insulet Corporation 2007 Employee Stock Purchase Plan on the following dates: 94 shares acquired on November 30, 2016, 117 shares acquired on May 31, 2017 and 195 shares acquired on November 30, 2017."}],"balance_after":44995,"source":{"system":"sec-edgar","filing":"0001127602-18-006481","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760218006481/form4.xml","form_type":"4"}},{"id":4055299,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Common Stock","published_at":"2018-02-16T01:07:39.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":11962,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 11,962 performance share units were granted on February 24, 2016, and the Compensation Committee of the Board of Directors determined on February 13, 2018 that the performance share units were earned based on the performance of the Company.  The full award remains subject to time-based vesting in accordance with the following schedule: one-half of the performance share units vest on the second anniversary of the date of grant and one-half of the performance share units vest on the third anniversary of the date of grant.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,209 restricted stock units granted on June 29, 2015, which vest on June 29, 2018; 4,557 restricted stock units granted on February 24, 2016, which vest one-half of the total units on February 24, 2018 and one-half of the total units on February 24, 2019; and 4,327 restricted stock units granted on February 22, 2017, which vest one-third of the total units on February 22, 2018, and one-third of the total units on February 22, 2019, and one-third of the total units on February 22, 2020, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes an aggregate of 406 shares acquired under the Insulet Corporation 2007 Employee Stock Purchase Plan on the following dates: 94 shares acquired on November 30, 2016, 117 shares acquired on May 31, 2017 and 195 shares acquired on November 30, 2017."}],"balance_after":42310,"source":{"system":"sec-edgar","filing":"0001127602-18-006481","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760218006481/form4.xml","form_type":"4"}},{"id":4424975,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-02-24T23:42:47.000Z","date":"2017-02-22","kind":"grant","acquired":true,"shares":11372,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment."}],"balance_after":11372,"derivative":{"exercise_price":46.22,"expiration_date":"2027-02-22","underlying":"Common Stock","underlying_shares":11372},"source":{"system":"sec-edgar","filing":"0001127602-17-008320","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760217008320/form4.xml","form_type":"4"}},{"id":4424974,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"officer":true,"officer_title":"SVP, Secretary and GC"}}],"security":"Common Stock","published_at":"2017-02-24T23:42:47.000Z","date":"2017-02-22","kind":"grant","acquired":true,"shares":4327,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 4,327 restricted stock units vest one-third of the total units on February 22, 2018, and one-third of the total units on February 22, 2019, and one-third of the total units on February 22, 2020, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 14,418 restricted stock units granted on June 29, 2015, which vest one-half of the total units on June 29, 2017 and one-half of the total units on June 29, 2018; and 4,557 restricted stock units granted on February 24, 2016, which vest one-half of the total units on February 24, 2018 and one-half of the total units on February 24, 2019, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 94 shares acquired on November 30, 2016 under the Insulet Corporation 2007 Employee Stock Purchase Plan."}],"balance_after":30442,"source":{"system":"sec-edgar","filing":"0001127602-17-008320","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760217008320/form4.xml","form_type":"4"}}]}